NC
SONM icon

Nokomis Capital’s DNA X Inc SONM Stock Holding History

Nokomis Capital’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-356
Closed -$464K – 48
2020
Q4 		$464K Sell
356
-1,037
-74% -$1.13M 0.2% 28
2020
Q3 		$1.95M Sell
1,393
-271
-16% -$436K 0.9% 22
2020
Q2 		$2.4M Sell
1,664
-387
-19% -$618K 1.09% 20
2020
Q1 		$2.58M Hold
2,051
– – 1.24% 17
2019
Q4 		$13.4M Hold
2,051
– – 4.09% 9
2019
Q3 		$10.8M Hold
2,051
– – 2.34% 13
2019
Q2 		$47M Buy
+2,051
New +$52M 9.22% 2

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nokomis Capital's SONM Position: Q1 2021 in Review

Nokomis Capital sold out of DNA X Inc (SONM) in Q1 2021, closing a stake of 356 shares — an estimated $464K sold.

Nokomis Capital first reported a position in SONM in Q2 2019 and held it in 7 quarters. The position peaked at $47M in Q2 2019. 23 funds tracked by Wall St. Rank hold SONM as of Q1 2021.

  • Nokomis Capital reported no remaining DNA X Inc position as of Q1 2021 after selling out during the quarter.
  • Nokomis Capital sold 356 DNA X Inc shares in Q1 2021, an estimated $464K.
  • Nokomis Capital first reported a position in DNA X Inc in Q2 2019 and held it in 7 quarters.
  • Nokomis Capital's DNA X Inc position peaked at $47M in Q2 2019.
  • 23 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2021.

Based on Nokomis Capital's 13F filing for Q1 2021, filed 17 May 2021.